Naohiro Wada

671 total citations
36 papers, 463 citations indexed

About

Naohiro Wada is a scholar working on Nephrology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Naohiro Wada has authored 36 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 10 papers in Molecular Biology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Naohiro Wada's work include Renal Diseases and Glomerulopathies (12 papers), Pediatric Urology and Nephrology Studies (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Naohiro Wada is often cited by papers focused on Renal Diseases and Glomerulopathies (12 papers), Pediatric Urology and Nephrology Studies (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Naohiro Wada collaborates with scholars based in Japan, France and United States. Naohiro Wada's co-authors include Masataka Honda, Shori Takahashi, Osamu Uemura, Motoshi Hattori, Koichi Nakanishi, Kensuke Harada, Sakurako Hoshii, Tetsuji Kaneko, Kenji Ishikura and Yuko Hamasaki and has published in prestigious journals such as Biochemistry, Kidney International and American Journal of Kidney Diseases.

In The Last Decade

Naohiro Wada

34 papers receiving 452 citations

Peers

Naohiro Wada

NEPHR

PPCH

PRM

SURGE

Doaa Mohammed Youssef Egypt

Thierry Schurmans Belgium

William Morello Italy

J H Ehrich Germany

O Otsubo Japan

K.-H. Shu Taiwan

Anne Maisin France

Go Kanzaki Japan

Giuseppe Picciotto Italy

Richard J. Johnson Australia

Doaa Mohammed Youssef Egypt

Naohiro Wada

145 ×0.6

NEPHR

76 ×0.5

104 ×0.9

PPCH

106 ×2.1

PRM

34 ×0.7

SURGE

Citations per year, relative to Naohiro Wada Naohiro Wada (= 1×) peers Doaa Mohammed Youssef

Countries citing papers authored by Naohiro Wada

Since Specialization

Citations

This map shows the geographic impact of Naohiro Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naohiro Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naohiro Wada more than expected).

Fields of papers citing papers by Naohiro Wada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naohiro Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naohiro Wada. The network helps show where Naohiro Wada may publish in the future.

Co-authorship network of co-authors of Naohiro Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Naohiro Wada. A scholar is included among the top collaborators of Naohiro Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naohiro Wada. Naohiro Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iwaki, Michihiro, Takashi Kobayashi, Naohiro Wada, et al.. (2025). Efficacy of Magnetic Resonance Elastography in Fontan‐Associated Liver Disease. JGH Open. 9(9). e70274–e70274. 1 indexed citations

Iwaki, Michihiro, Masato Yoneda, Naohiro Wada, et al.. (2024). Emerging drugs for the treatment of hepatic fibrosis on nonalcoholic steatohepatitis. Expert Opinion on Emerging Drugs. 29(2). 127–137. 1 indexed citations

Kobayashi, Takashi, Michihiro Iwaki, Naohiro Wada, et al.. (2024). Paradigm shift in steatotic liver disease (SLD): from NAFLD to MASLD. Kanzo. 65(9). 420–432.

Nogami, Asako, Naohiro Wada, Michihiro Iwaki, et al.. (2023). Mortality associated with the development of acute liver failure after a single dose of nivolumab. Clinical Journal of Gastroenterology. 16(3). 464–469. 4 indexed citations

Hamada, Riku, Tetsuji Kaneko, Osamu Uemura, et al.. (2022). Urine alpha 1-microglobulin-to-creatinine ratio and beta 2-microglobulin-to-creatinine ratio for detecting CAKUT with kidney dysfunction in children. Pediatric Nephrology. 38(2). 479–487. 7 indexed citations

Wada, Naohiro, et al.. (2021). β2‐microglobulin measurement with dried urine spots for congenital anomalies of the kidney and urinary tract screening in 3‐year‐old children. Pediatrics International. 64(1). e15077–e15077. 4 indexed citations

Miyano, Go, China Nagano, Keiichi Morita, et al.. (2016). A Case of Juxtaglomerular Cell Tumor, or Reninoma, of the Kidney Treated by Retroperitoneoscopy-Assisted Nephron-Sparing Partial Nephrectomy Through a Small Pararectal Incision. Journal of Laparoendoscopic & Advanced Surgical Techniques. 26(3). 235–238. 3 indexed citations

Nagai, Takuhito, Osamu Uemura, Hisashi Kaneda, et al.. (2016). The true distribution volume and bioavailability of mizoribine in children with chronic kidney disease. Clinical and Experimental Nephrology. 21(5). 884–888. 2 indexed citations

Hamasaki, Yuko, Kenji Ishikura, Osamu Uemura, et al.. (2015). Growth impairment in children with pre-dialysis chronic kidney disease in Japan. Clinical and Experimental Nephrology. 19(6). 1142–1148. 9 indexed citations

10.

Kaneda, Hisashi, Masaki Shimizu, Kazuhide Ohta, et al.. (2015). Population pharmacokinetics of mizoribine in pediatric patients with kidney disease. Clinical and Experimental Nephrology. 20(5). 757–763. 4 indexed citations

11.

Hirano, Daishi, Kenji Ishikura, Osamu Uemura, et al.. (2015). Association between low birth weight and childhood-onset chronic kidney disease in Japan: a combined analysis of a nationwide survey for paediatric chronic kidney disease and the National Vital Statistics Report. Nephrology Dialysis Transplantation. 31(11). 1895–1900. 33 indexed citations

12.

Wada, Naohiro, et al.. (2014). Analysis of the risk factors of acute tubulointerstitial nephritis caused by Yersinia pseudotuberculosis infection. Japanese journal of pediatric nephrology. 26(2). 187–193.

13.

Ishikura, Kenji, Osamu Uemura, Yuko Hamasaki, et al.. (2014). Progression to end-stage kidney disease in Japanese children with chronic kidney disease: results of a nationwide prospective cohort study. Nephrology Dialysis Transplantation. 29(4). 878–884. 25 indexed citations

14.

Kaneda, Hisashi, Osamu Uemura, Kazuhide Ohta, et al.. (2010). Evaluation of Limited Sampling Designs to Estimate Maximal Concentration and Area under the Curve of Mizoribine in Pediatric Patients with Renal Disease. Drug Metabolism and Pharmacokinetics. 26(1). 71–78. 8 indexed citations

15.

Iwashima, Satoru, Satoru Tsuruta, Kozo Mutoh, et al.. (2008). A Multi-center Study on Treatment of Kawasaki Disease. 112(8). 1227–1232. 1 indexed citations

16.

Hoshii, Sakurako, et al.. (2006). A survey of peritonitis and exit-site and/or tunnel infections in Japanese children on PD. Pediatric Nephrology. 21(6). 828–834. 24 indexed citations

17.

Sako, Mayumi, Koichi Nakanishi, Nahoko Yata, et al.. (2005). Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney International. 67(4). 1248–1255. 61 indexed citations

18.

Yonemura, Katsuhiko, et al.. (2004). The diagnostic value of serum concentrations of 2-(α-mannopyranosyl)-l-tryptophan for normal renal function. Kidney International. 65(4). 1395–1399. 22 indexed citations

19.

Takahashi, Shori, Naohiro Wada, Kensuke Harada, & Michio Nagata. (2004). Cationic charge-preferential IgG reabsorption in the renal proximal tubules. Kidney International. 66(4). 1556–1560. 11 indexed citations

20.

Maruyama, Kyoko, Kazumoto Iijima, Masahiro Ikeda, et al.. (2003). NPHS2 mutations in sporadic steroid-resistant nephrotic syndrome in Japanese children. Pediatric Nephrology. 18(5). 412–416. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact